Citadel Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Citadel Advisors's AMPH Position: Q3 2026 in Review
Citadel Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 713% in Q3 2026, buying an estimated $2.5M and bringing the position to 132,022 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #5600.
Citadel Advisors first reported a position in AMPH in Q3 2014 and has held it in 42 quarters since. The position peaked at $10.5M in Q2 2024. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Citadel Advisors held 132,022 shares of Amphastar Pharmaceuticals worth $3.41M as of Q3 2026.
- Citadel Advisors bought 115,791 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $2.5M.
- Amphastar Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #5600 holding.
- Citadel Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 42 quarters since.
- Citadel Advisors's Amphastar Pharmaceuticals position peaked at $10.5M in Q2 2024.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.